Patents by Inventor Janet Rubin

Janet Rubin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11918822
    Abstract: The present invention relates to compositions and methods configured to deliver a stimulus (e.g., a therapeutic agent or a therapeutically beneficial signal) to a cell, tissue, organ, or organism. The stimulus is applied at least twice, and the first and second applications are separated by a rest period in which no further stimulus is actively applied. The rest period is of a duration (e.g., about 1-6 hours) sufficient to provoke an enhanced response to the second stimulus.
    Type: Grant
    Filed: October 19, 2022
    Date of Patent: March 5, 2024
    Assignees: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
    Inventors: Clinton Rubin, Janet Rubin
  • Publication number: 20230173292
    Abstract: The present invention relates to compositions and methods configured to deliver a stimulus (e.g., a therapeutic agent or a therapeutically beneficial signal) to a cell, tissue, organ, or organism. The stimulus is applied at least twice, and the first and second applications are separated by a rest period in which no further stimulus is actively applied. The rest period is of a duration (e.g., about 1-6 hours) sufficient to provoke an enhanced response to the second stimulus.
    Type: Application
    Filed: October 19, 2022
    Publication date: June 8, 2023
    Inventors: Clinton Rubin, Janet Rubin
  • Publication number: 20210393972
    Abstract: The present invention relates to compositions and methods configured to deliver a stimulus (e.g., a therapeutic agent or a therapeutically beneficial signal) to a cell, tissue, organ, or organism. The stimulus is applied at least twice, and the first and second applications are separated by a rest period in which no further stimulus is actively applied. The rest period is of a duration (e.g., about 1-6 hours) sufficient to provoke an enhanced response to the second stimulus.
    Type: Application
    Filed: June 22, 2021
    Publication date: December 23, 2021
    Inventors: Clinton Rubin, Janet Rubin
  • Patent number: 11040215
    Abstract: The present invention relates to compositions and methods configured to deliver a stimulus (e.g., a therapeutic agent or a therapeutically beneficial signal) to a cell, tissue, organ, or organism. The stimulus is applied at least twice, and the first and second applications are separated by a rest period in which no further stimulus is actively applied. The rest period is of a duration (e.g., about 1-6 hours) sufficient to provoke an enhanced response to the second stimulus.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: June 22, 2021
    Assignee: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS). U.S. GOVERNMENT NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
    Inventors: Clinton Rubin, Janet Rubin
  • Publication number: 20190030317
    Abstract: The present invention relates to compositions and methods configured to deliver a stimulus (e.g., a therapeutic agent or a therapeutically beneficial signal) to a cell, tissue, organ, or organism. The stimulus is applied at least twice, and the first and second applications are separated by a rest period in which no further stimulus is actively applied. The rest period is of a duration (e.g., about 1-6 hours) sufficient to provoke an enhanced response to the second stimulus.
    Type: Application
    Filed: July 20, 2018
    Publication date: January 31, 2019
    Inventors: Clinton RUBIN, Janet RUBIN
  • Patent number: 10029089
    Abstract: The present invention relates to compositions and methods configured to deliver a stimulus (e.g., a therapeutic agent or a therapeutically beneficial signal) to a cell, tissue, organ, or organism. The stimulus is applied at least twice, and the first and second applications are separated by a rest period in which no further stimulus is actively applied. The rest period is of a duration (e.g., about 1-6 hours) sufficient to provoke an enhanced response to the second stimulus.
    Type: Grant
    Filed: October 14, 2011
    Date of Patent: July 24, 2018
    Assignees: RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE, NORTH CAROLINA AT CHAPEL HILL, UNIVERSITY OF
    Inventors: Clinton Rubin, Janet Rubin
  • Publication number: 20130288260
    Abstract: The present invention relates to compositions and methods configured to deliver a stimulus (e.g., a therapeutic agent or a therapeutically beneficial signal) to a cell, tissue, organ, or organism. The stimulus is applied at least twice, and the first and second applications are separated by a rest period in which no further stimulus is actively applied. The rest period is of a duration (e.g., about 1-6 hours) sufficient to provoke an enhanced response to the second stimulus.
    Type: Application
    Filed: October 14, 2011
    Publication date: October 31, 2013
    Applicant: The Research Foundation of State University of New York
    Inventors: Clinton Rubin, Janet Rubin